Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1993-9-1
pubmed:abstractText
alpha 2-Macroglobulin (alpha 2M) undergoes a major conformational change when reacting with proteinases or primary amines. This conformational change has been referred to as the 'slow' to 'fast' transformation based on the increase in alpha 2M mobility shown by non-denaturing PAGE. Previous studies demonstrated that many cytokines, including transforming growth factor beta 1 (TGF-beta 1) and interleukin-1 beta, bind preferentially or exclusively to alpha 2M which has undergone conformational change. In this study, we demonstrate that platelet-derived growth factor-BB (PDGF-BB) also binds preferentially to conformationally transformed alpha 2M (alpha 2M-methylamine, alpha 2M-trypsin) in vitro. Purified 125I-PDGF-BB-alpha 2M-methylamine complex cleared rapidly from the circulation of mice via the alpha 2M receptor/low-density-lipoprotein-receptor-related protein (alpha 2M-R/LRP). In order to determine whether PDGF-BB or TGF-beta 1 binds to native alpha 2M, we defined the native conformation by lack of interaction with alpha 2M-R/LRP instead of electrophoretic mobility. 125I-PDGF-BB was incubated with 4.3 microM native alpha 2M and 0.47 microM alpha 2M-methylamine. The 125I-PDGF-BB distributed evenly between slow-form and fast-form alpha 2M without shifting the electrophoretic mobility of either species. When the mixed preparation was injected intravenously in mice, 125I-PDGF-BB-fast-form-alpha 2M cleared rapidly and selectively from the circulation; 125I-PDGF-BB which was bound to slow-form alpha 2M was stable in the blood (apparently not recognized by alpha 2M-R/LRP). Therefore, while conformationally transformed alpha 2M binds PDGF-BB preferentially in vitro, non-alpha 2M-R/LRP-recognized alpha 2M binds PDGF-BB as well. Binding of 125I-PDGF-BB and 125I-TGF-beta 1 to alpha 2M was demonstrated in vivo by injecting the free growth factors intravenously into mice. Plasma samples which were subjected to non-denaturing PAGE and autoradiography demonstrated binding of both growth factors exclusively to the slow-form of alpha 2M. Therefore, under normal physiological conditions, native alpha 2M (non-alpha 2M-R/LRP-recognized) is the primary form of the proteinase inhibitor functioning as a carrier of PDGF-BB and TGF-beta 1 in the blood.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1280859, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1281457, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1370602, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1371050, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1372906, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1373682, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1377675, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1379978, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1423505, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1632469, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-16496527, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1693530, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1698775, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1698792, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1700994, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1702100, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1704186, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1710516, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1712069, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-1718991, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2410017, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2426272, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2427362, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2443501, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2447091, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2452653, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2461679, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2466831, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2475504, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2874805, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-2891016, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-4166401, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-4201304, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6161841, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6166004, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6167573, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6167585, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6181812, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6186243, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6189480, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6196365, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6198647, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-6203121, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-80217, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-86541, http://linkedlifedata.com/resource/pubmed/commentcorrection/7688216-91367
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
293 ( Pt 2)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
443-50
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
More...